Navigation Links
Par Pharmaceutical Reports First Quarter 2008 Results
Date:5/8/2008

oduct competition on existing products, and the market opportunity of some of Par's generic pipeline products. Full year 2008 earnings per diluted share are projected to be $0.65 to $0.85, excluding anticipated pre-launch spending and milestone payments in support of Strativa's business strategy and including the estimated impact of four new generic product launches (i.e., sumatriptan vials and kits, clonidine, dronabinol, certain strengths of risperidone ODT) with an expected fully diluted EPS impact of $0.25 to $0.47.

2009-2012 Generic Pipeline

The Company's investment in its generic first-to-file development strategy has lead to a growing pipeline and a track record of first-to-file drugs. The Company anticipates that it will launch as many as 15 new products during 2009 and 2012 based on the expiration of 30 month stay periods or prior settlements.

To provide investors with additional information by which to analyze the Company, Par is providing a range of estimated values for certain key generic pipeline products. These values are based on projections regarding the first six months of net sales and the anticipated gross margin of each product in the year the product launches. Since each full six-month period may not be in the calendar year the product launches, we anticipate that some of the value will be realized in the next calendar year. (Please note that these estimates do not include value after the initial six months following product launch).

In 2009, Par anticipates six key generic product launches that are expected to have a range of net sales and gross margin of $95-$135 million and $78-$110 million, respectively, to the Company. In 2010, Par anticipates five key generic product launches that are expected to have a range of net sales and gross margin of $60-$80 million and $42-$56 million, respectively, to the Company. In 2011, Par anticipates two key generic launches that are expected to have a range of net sales and gross
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vion Pharmaceuticals to Appeal Nasdaq Delisting
2. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
3. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
4. Par Pharmaceutical Acquires Spectrum Pharmaceuticals Interest In Sumatriptan Injection
5. ISTA Pharmaceuticals to Present at the Bank of America 2008 Health Care Conference
6. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
7. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
8. Par Pharmaceutical to Host First Quarter 2008 Earnings Conference Call on May 9 at 9:00 AM
9. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
10. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
11. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Viejo, CA (PRWEB) June 02, 2015 TranSlice: ... with a new style. TranSlice: Reveal allows Final Cut Pro ... and growing lines to reveal their next screen. , TranSlice ... unique style. Final Cut Pro X users can ... and growing lines. , With every panel orientation and direction ...
(Date:6/2/2015)... Amercanex, the American Cannabis Exchange, ... become Amercanex’s new Chief Technology Officer. Amercanex is ... cultivators, wholesale distributors and retail vendors can buy, ... transparent intra-state market. , Jim Miller is an ... space, helping innovative technology companies deliver on their ...
(Date:6/2/2015)... June 02, 2015 Thermi, formerly ... company has successfully transitioned into its new company ... to the company’s continued rapid worldwide expansion and ... of over 25 Thermi employees, including those of ... teams. , “As one of the fastest growing ...
(Date:6/2/2015)... Atlantic Spine Center , a ... three locations in New Jersey, announces the opening of ... facility is at 1045 Park Avenue (at East 86th ... can be arranged by calling 1-844-912-2406. , Dr. ... Center, has been a pioneer in the development of ...
(Date:6/2/2015)... June 02, 2015 Specialty Technical ... compliance and risk solutions , and Radar today ... management effectiveness gap-improvement program. , All organizations need ... on objectives. Organizations not only assess and treat ... to do this (risk managing) thereby embedding these ...
Breaking Medicine News(10 mins):Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... , Feb. 16 In these difficult times in ... bringing money and services into the Reno area.   ... Start Learning Disabilities Programs Inc. is providing cutting edge educational and ... The $200,000.00 represents a net investment into the area. ...
... University researchers have developed a hands-free alternative to cell phone ... doing it, make it safer," said Juan Gilbert, professor and ... Computing. He said one problem with banning texting while ... He said it will be difficult for police to can,t ...
... radiological evidence suggest broken leg, malaria and genetic disorder ... King Tut probably wasn,t killed by a vengeful wife ... a broken leg and several inherited disorders that rendered ... new DNA and radiological evidence suggests. , "What ...
... Washington, DC Combining tamoxifen, the world,s most prescribed breast ... feverfew may prevent initial or future resistance to the drug, ... reported online in FASEB Feb. 12, provides ... also tests a novel way to get around it. "A ...
... them with a laser has been shown to be a ... occur in places where a laser light can,t reach? Scientists ... directing gold nanoparticles into the nuclei of cancer cells, they ... them where they lurk. The research appeared as a communication ...
... peer-reviewed international journal of the American Cancer Society, ... in its Jan. 1 edition, demonstrating disparities in ... white women. The HealthCore study reiterates ... populations using government health programs that African-American ...
Cached Medicine News:Health News:Reno Children With Disabilities Profit From a Little Known but Internationally Recognized Non-Profit Organization as it Quietly Crosses the $200,000.00 Mark in Service Investment Into the Reno Area 2Health News:King Tut's Demise Gets New Explanation 2Health News:King Tut's Demise Gets New Explanation 3Health News:GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen 2Health News:GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen 3Health News:Using gold nanoparticles to hit cancer where it hurts 2Health News:Cancer publishes study confirming disparity in breast cancer treatment 2
(Date:6/1/2015)... June 2, 2015 Islamic ... mainstream reporting standard for Corporate Sustainability and Social ... big step in CSR: The Islamic Reporting Initiative (IRI). ... last month, the Islamic Reporting Initiative is rapidly ... The latest members to express support for ...
(Date:6/1/2015)... -- LaunchPad Medical, LLC announced today that it has ... Corporation,s (NYSE: SYK ) bone adhesive technology, ... Under the terms of the agreement, LaunchPad has ... this technology which is covered by four issued ... from multiple pre-clinical animal studies.  LaunchPad will seek ...
(Date:6/1/2015)... WOODBRIDGE, ON , June 1, 2015 /PRNewswire/ ... a specialty pharmaceutical company with a focus on ... health, announced its operational highlights and financial results ...  All dollar amounts referenced herein are in Canadian ... to deliver on its business strategies despite its ...
Breaking Medicine Technology:Call for Partners: Islamic CSR 2LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology 2Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5
For reconstruction, trauma and chronic stenosis of canalicular system. Medical grade silicone tubing (tapered at one end). Blue polypropylene suture. Box of 3, sterile....
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
For proper plug sizing....
For proper plug sizing....
Medicine Products: